Shares of insurance and pharmacy benefit manager (PBM) companies such as Centene Corp ( CNC ). , Elevance Health Inc. ( ELV ) , Humana Inc. ( HUM ) and CVS Health Corp ( CVS ). are trading lower Thursday, likely in reaction to UnitedHealth Group Inc. ( UNH )‘s disappointing fourth-quarter 2024 revenue results.

What To Know: UnitedHealth ( UNH ), the largest health insurer in the U.S., reported a revenue increase of 6.8% year-over-year to $100.8 billion, falling short of the consensus estimate of $101.76 billion.

UnitedHealth’s stock declined sharply, falling 6.04% to $510.59, as the earnings report highlighted concerns over its medical care ratio, which rose to 85.5% from 83.2% in 2023. This increase was attributed to factors such as Medicare funding reductions, member mix changes and the timing of Medicaid redeterminations.

UnitedHealth ( UNH ) also reaffirmed its 2025 guidance, projecting $450 billion to $455 billion in revenue and adjusted EPS of $29.50 to $30.00.

The broader sector saw a ripple effect. The declines potentially reflect investor apprehension about sector-wide pressures, including reimbursement challenges and operational costs, spotlighted by UnitedHealth’s earnings report.

Price Actions: Closing Thursday, Centene ( CNC ) stock dropped 0.44% to $62.87, CVS Health ( CVS ) slid 0.15% to $51.96, Elevance Health ( ELV ) fell 1.03% to $385.26 and Humana dropped 1.62% to $274.97 according to Benzinga Pro.

Read Next:

Dave Ramsey Breaks Down How A $40,000 Car Depreciates By $16,000 Over 5 Years, Says It’s Not A Path To Prosperity, Even On An $80,000 Salary